<DOC>
	<DOCNO>NCT01713075</DOCNO>
	<brief_summary>The purpose investigation confirm safety efficacy long-term use Symbicort Turbuhaler patient Chronic obstructive pulmonary disease ( COPD ) post-marketing actual use .</brief_summary>
	<brief_title>Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation Long-term Use Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation long-term use COPD patient</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Among patient treat Symbicort Turbuhaler due chronic obstructive pulmonary disease ( COPD ) , receive drug first time .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>Symbicort</keyword>
	<keyword>long-term use</keyword>
</DOC>